1. Will other drugmakers end up with deals like Endo’s $10M opioid settlement? — AstraZeneca Imfinzi combo fails advanced lung cancer study — FDA says they were “lucky” with Novartis data manipulation controversy — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Allergan

Anonymous board for Allergan

Sort By:
Title
Replies ↓ Views
Last Message
  1. Shoham
    Replies:
    1,171
    Views:
    380,634
  2. anonymous
    Replies:
    764
    Views:
    103,102
  3. anonymous
    Replies:
    435
    Views:
    58,419
  4. Anonymous
    Replies:
    350
    Views:
    66,214
  5. Anonymous
    Replies:
    277
    Views:
    114,212
  6. Anonymous
    Replies:
    233
    Views:
    71,733
  7. Anonymous
    Replies:
    192
    Views:
    24,625
  8. anonymous
    Replies:
    187
    Views:
    35,736
  9. Anonymous
    Replies:
    175
    Views:
    33,511
  10. anonymous
    Replies:
    164
    Views:
    58,365
  11. Anonymous
    Replies:
    162
    Views:
    175,635
  12. Anonymous
    Replies:
    162
    Views:
    30,929
  13. Anonymous
    Replies:
    146
    Views:
    31,940
  14. anonymous
    Replies:
    145
    Views:
    15,913
  15. Anonymous
    Replies:
    143
    Views:
    30,904
  16. anonymous
    Replies:
    137
    Views:
    12,469
  17. anonymous
    Replies:
    129
    Views:
    22,115
  18. Anonymous
    Replies:
    114
    Views:
    33,606
  19. anonymous
    Replies:
    113
    Views:
    31,615
  20. Anonymous
    Replies:
    111
    Views:
    50,821

Thread Display Options

Loading...